Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06511453 · ClinicalTrials.gov registry record · NA

Acupressure in Patients With Sickle Cell Disease

A NA study of Sickle Cell Disease, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
2
Study locations

NCT06511453 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by Indiana University. The registered enrollment target is 240 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (18% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06511453, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
2
Study locations

Study Summary

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

Conditions Studied

Sickle Cell Disease

Interventions

  • DEVICE Acupressure (using AcuWand or pencil eraser)

Study Locations (2)

California

  • University of California, Irvine - Irvine

Indiana

  • Indiana University School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2024-03-07
Est. Completion 2029-08
Phase NA

Sponsor

Indiana University

890 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06511453

The ClinicalTrials.gov registry entry for NCT06511453 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (18% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Acupressure (using AcuWand or pencil eraser) is the first listed.

NCT06511453 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Indiana.

Frequently Asked Questions

What is clinical trial NCT06511453 about?

NCT06511453 is a clinical study titled "Acupressure in Patients With Sickle Cell Disease". The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

What is the current status of trial NCT06511453?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2024-03-07. Estimated completion is 2029-08.

What conditions does trial NCT06511453 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT06511453?

The interventions under investigation include: Acupressure (using AcuWand or pencil eraser) (DEVICE).

Who is sponsoring clinical trial NCT06511453?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06511453 being conducted?

This trial has 2 study locations across California, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sickle Cell Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.